High Expression of Caspase-8 Associated with Improved Survival in Diffuse Large B-Cell Lymphoma: Machine Learning and Artificial Neural Networks Analyses
نویسندگان
چکیده
High expression of the anti-apoptotic TNFAIP8 is associated with poor survival patients diffuse large B-cell lymphoma (DLBCL), and one functions to inhibit pro-apoptosis Caspase-8. We aimed analyze immunohistochemical Caspase-8 (active subunit p18; CASP8) in a series 97 cases DLBCL from Tokai University Hospital, correlate other pathway-related markers, including cleaved Caspase-3, PARP, BCL2, TP53, MDM2, MYC, Ki67, E2F1, CDK6, MYB LMO2. After digital image quantification, correlation several clinicopathological characteristics showed that high protein was favorable overall progression-free (Hazard Risks = 0.3; p 0.005 0.03, respectively). also positively correlated cCASP3, TNFAIP8, BCL2 Ki67. Next, modeled using predictive analytics, accuracy (>80%) obtained CHAID decision tree, Bayesian network, discriminant analysis, C5 logistic regression, Artificial Intelligence Neural Network methods (both Multilayer perceptron Radial basis function); most relevant markers were cPARP, TNFAIP8. Finally, CASP8 gene successfully an independent 414 Lymphoma/Leukemia Molecular Profiling Project (LLMPP). In conclusion, prognosis DLBCL. Predictive modeling feasible analytic strategy results solution can be understood (i.e., explainable artificial intelligence, “white-box” algorithms).
منابع مشابه
BCL2 Family Related Genes Expression and Chemotherapy Response in Diffuse Large B-Cell Lymphoma
Background and Objective: Approximately half of patients with diffuse large B-cell lymphoma are cured with current chemotherapy regimens. The purpose of this study was to evaluate Bax and Bcl2 expression and their relationship with the response to chemotherapy. Materials and Methods This study was a prospective analysis on 44 patients with diffuse large B-cell lymphoma. Their specimens we...
متن کاملIncreased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
BACKGROUND Obesity is a well-known risk factor for the development of several types of cancer including lymphomas, but its influence on the course of disease is fairly unknown. Recently, a retrospective cancer registry analysis demonstrated significantly prolonged survival for overweight and obese patients with diffuse large B-cell lymphoma (DLBCL). The study population almost exclusively consi...
متن کاملMeasurement of pyruvate dehydrogenase enzyme in patients with diffuse large B-cell lymphoma relapse
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), which is the most common type of lymphoma. NHL comprises a group of clinically and biologically diverse diseases, which range from indolent to aggressive clinical courses. Despite treatment advances in the last three decades with the use of combination immunotherapy, a significant fraction...
متن کاملPrimary Hepatic Diffuse Large B-Cell Lymphoma in a Patient with Scleroderma
Primary Hepatic Lymphoma (PHL) is rare and possibly associated with viral hepatitis and autoimmune diseases. Scleroderma could exceptionally be complicated by lymphoma. We describe PHL occurring in a 52-year-old female suffering scleroderma for eight years, with no history of cytotoxic or high-dose glucocorticoid therapy. CT scan, performed to work-up abdominal discomfort, constipation, and ...
متن کاملLow GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma
The major histocompatibility complex (MHC) class II-restricted antigen processing pathway presents antigenic peptides acquired in the endocytic route for the activation of CD4(+) T cells. Multiple cancers express MHC class II, which may influence the anti-tumor immune response and patient outcome. Low MHC class II expression is associated with poor survival in diffuse large B-cell lymphoma (DLB...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BioMedInformatics
سال: 2021
ISSN: ['2673-7426']
DOI: https://doi.org/10.3390/biomedinformatics1010003